A series of infections due to Capnocytophaga spp. in immunosuppressed and immunocompetent patients

Clinical Microbiology and Infection

Volumn 9, Issue 5, 2003, Pages 380-387

  Bonatti, Hugo ^a   Rossboth, D W ^a   Nachbaur, D ^a   Fille, M ^a   Aspock C ^b   Hend, I ^b   Hourmont, K ^a   White, L ^c   Malnick, H ^d   Allerberger, F J ^d  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

Capnocytophaga; Empyema; Immunocompetent; Immunosuppression; Sepsis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBON DIOXIDE; CEFALOTIN; CEFAMANDOLE; CEFOTAXIME; CEFOXITIN; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; FOSFOMYCIN; GLYCOPEPTIDE; MACROLIDE; MANGANESE; METRONIDAZOLE; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ADULT; AGED; ANAEROBIC GROWTH; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CAPNOCYTOPHAGA; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE COURSE; EPIDEMIOLOGY; ERADICATION THERAPY; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LEUKOCYTE COUNT; MALE; MEDICAL DOCUMENTATION; MICROBIOLOGY; NEUTROPENIA; PLEURA EMPYEMA; PRIORITY JOURNAL; SEPTICEMIA; UNITED KINGDOM; UNIVERSITY HOSPITAL;

BACTERIA (MICROORGANISMS); CAPNOCYTOPHAGA; NEGIBACTERIA;

EID: 20244369224     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00538.x     Document Type: Article

References (22)

1. Gill VJ. Capnocytophaga. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Benett's principles and practice of infectious diseases, 5th edn. New York, NY: Churchill Livingston, 2000:2441-4.
2. Kristensen B, Schonheyder HC, Peterslund NA, Rosthoj S, Clausen N, Frederiksen W. Capnocytophaga (Capnocytophaga ochracea group) bacteremia in hematological patients with profound granulocytopenia. Scand J Infect Dis 1995; 27(2): 153-5.
3. Lion C, Escande F, Burdin JC. Capnocytophaga canimorsus infections in human: review of the literature and cases report. Eur J Epidemiol 1996; 12(5): 521-33.
4. Bilgrami S, Bergstrom SK, Peterson DE et al. Capnocytophaga bacteremia in a patient with Hodgkin's disease following bone marrow transplantation: case report and review. Clin Infect Dis 1992; 14: 1045-9.
5. Nonnenmacher C, Mutters R, de Jacoby LF. Microbiological characteristics of subgingival microbiota in adult periodontitis, localized juvenile periodontitis and rapidly progressive periodontitis subjects. Clin Microbiol Infect 2001; 7(4): 213-17.
6. Brenner DJ, Hollis DG, Fanning GR, Weaver RE. Capnocytophaga canimorsus; sp. nov., a cause of localized wound infection following dog bite. J Clin Microbiol 1989; 27: 231.
7. Baquero F, Fernandez J, Dronda F et al. Capnophilic and anaerobic bacteremia in neutropenic patients: an oral source (pathogenesis and immune mechanisms of anaerobic infections). Rev Infect Dis 1990; 12: 157-60.
8. Ochiai K, Senpuku H, Kurita-Ochiai T. Purification of immunosuppressive factor from Capnocytophaga ochracea. J Med Microbiol 1998; 47(12): 1087-95.
9. Parenti DM, Snydman DR. Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts. J Infect Dis 1985; 151(1): 140-7.
10. Reisner BS, Woods GL, Thomson Jr RB, Larone DH, Garcia LS, Shimizu RY. Specimen processing. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 7th edn. Washington, DC: ASM Press, 1999:64-104.
11. Mutters R. Actinobacillus, Capnocytophaga, Eikenella, Kingella and other fastidious or rarely encountered Gram-negative rods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 7th edn. Washington, DC: ASM Press, 1999:561-71.
12. Ungeheuer J, Wilms S, Sietzen W. MecA-gene in staphylococci-facilitated identification using PCR (MecA-General bei Staphylokokken-Vereinfachter Nachweis mit der PCR). Chemother J 1994; 3(1): 31.
13. Kirchmair R, Allerberger F, Bangerl I et al. Spontaneous bacterial pleural empyema in liver cirrhosis. Dig Dis Sci 1998; 43(5): 1129-32.
14. Hourmont K, Klingler PJ, Wetscher G, Kafka R, Bonatti H. Capnocytophaga pleural empyema following laparascopic Nissen fundoplication: a rare complication, a rare pathogen. Surg Endosc 2000; 14(9): 866.
15. Anne C, Fenelon G, Fenelon L. Unusual infections and novel therapy in the immunocompromised host. Curr Opin Infect Dis 2000; 13; 361-6.
16. Sawmiller CJ, Dudrick SJ, Hamzi M. Postsplenectomy Capnocytophaga canimorsus sepsis presenting as an acute abdomen. Arch Surg 1998; 133(12): 1362-5.
17. Sinnott JT 4th, Cullison JP, Blanco PJ. Capnocytophaga. Infect Control Hosp Epidemiol 1988; 9(4): 170-3.
18. Arlet G, Sanson-Le Pors MJ, Casin IM, Ortenberg M, Perol Y. In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones. Antimicrob Agents Chemother 1987; 31(8): 1283-4.
19. Jolivet-Gougeon A, Buffet A, Dupuy C et al. In. vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors. Antimicrob Agents Chemother 2000; 44(11): 3186-8.
20. Martino R, Ramila E, Capdevila JA et al. Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study. Clin Infect Dis 2001; 33(4): E20-2.
21. Brann OS. Infectious complications of cirrhosis. Curr Gastroenterol Rep 2001; 3(4): 285-92.
22. Ciantar M, Spratt DA, Newman HN, Wilson M. Assessment of five culture media for the growth and isolation of Capnocytophaga spp. Clin Microbiol Infect 2001; 7(3): 158-60.